[Federal Register Volume 77, Number 226 (Friday, November 23, 2012)]
[Notices]
[Page 70188]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-28486]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Cayman Chemical Company

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 25, 2012, Cayman 
Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, 
made application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
JWH-250 (6250).............................  I
SR-18 also known as RCS-8 (7008)...........  I
JWH-019 (7019).............................  I
JWH-081 (7081).............................  I
SR-19 also known as RCS-4 (7104)...........  I
JWH-122 (7122).............................  I
AM-2201 (7201).............................  I
JWH-203 (7203).............................  I
2C-T-2 (7385)..............................  I
JWH-398 (7398).............................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
2C-D (7508)................................  I
2C-E (7509)................................  I
2C-H (7517)................................  I
2C-I (7518)................................  I
2C-C (7519)................................  I
2C-N (7521)................................  I
2C-P (7524)................................  I
2C-T-4 (7532)..............................  I
AM-694 (7694)..............................  I
Phenylacetone (8501).......................  I
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for distribution to their research and forensics customers conducting 
drug testing and analysis.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than January 22, 2013.

    Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-28486 Filed 11-21-12; 8:45 am]
BILLING CODE 4410-09-P